NASHVILLE, Tenn. / Jun 26, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 2Q Earnings Release Call |
When: | Thursday, July 27, 2023 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$335.55 |
| Daily Change: | -5.07 -1.49 |
| Daily Volume: | 974,226 |
| Market Cap: | US$84.990B |
February 20, 2025 February 18, 2025 October 25, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
